CTI Molecular Imaging posts double-digit revenue gain

CTI Molecular Imaging Inc. said that it has made "a good start" in its first fiscal quarter, ending Dec. 31, 2003, to balance long-term growth with its quarterly objective to meet and exceed earnings per share goals.

Net revenues rose 22 percent to $74.1 million, compared with $60.6 million in the first quarter of FY03. Net income slipped to $700,000, compared with $3.4 million in the year-ago quarter.

In the quarter, CTI shipped 26 scanners and booked orders for an additional 55 units. Twenty-one of those scanners shipped through CTI's partners and distributors, while 36 of its 55 orders came through those same channels. Those results compare with a total of 30 scanners shipped and 56 total orders taken in the year-ago quarter.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.